関連する実験動画
Updated: Jul 8, 2026

10:43
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
Published on: October 31, 2007
1型糖尿病患者の臓リンパ節からの拡張T細胞は,インスリンエピトープを認識する
Sally C Kent1, Yahua Chen, Lisa Bregoli
1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature
|May 13, 2005
まとめ
研究者らは1型糖尿病患者のインスリン反応性T細胞を特定した. 臓のリンパ節にあるこれらの拡張T細胞は,インスリンが自己免疫糖尿病における重要な自己抗原であることを示唆しています.
科学分野:
- 免疫学 免疫学とは
- エンドクリノロジー エンドクリノロジー
- 自己免疫とは,自己免疫である.
背景:
- 1型自己免疫糖尿病では,Tリンパ球がインスリンを産生するベータ島細胞を破壊します.
- この自己免疫反応を誘発する特定の自己抗原を特定することは,疾患の病原性を理解するために極めて重要です.
研究 の 目的:
- 胰腺の排水リンパ節内のT細胞を調査するために,小島細胞のオートアンチゲンプレゼンテーションの主要なサイトです.
- 1型糖尿病患者の拡張T細胞によって認識される自己抗原を特定する.
主な方法:
- 1型糖尿病患者および非糖尿病の対照群の臓を排水するリンパ節から単一のT細胞をクローンした.
- T細胞のクローナリティと抗原認識が評価され,特にDR4感受性アレルに関連して評価されました.
主要な成果:
- 長期的な1型糖尿病患者の臓リンパ節にT細胞の有意なクローン拡張が観察されたが,対照群には認められなかった.
- DR4陽性糖尿病患者のオリゴクローナル拡張T細胞は,DR4.4によって制限されたインスリンA1-15エピトープを認識しました.
結論:
- インスリン反応性,クローン的に拡張したT細胞は,長期的な1型糖尿病における自己免疫性排水部位で特定されました.
- これらの発見は,インスリンが自己免疫性糖尿病の原因となる主要な標的自己抗原であることを強く示している.
関連する概念動画
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

